SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-024451
Filing Date
2024-05-21
Accepted
2024-05-21 08:31:33
Documents
6
Effectiveness Date
2024-05-21

Document Format Files

Seq Description Document Type Size
1 S-8 lenz-sx8.htm S-8 87472
2 EX-FILING FEES exhibit107-sx8.htm EX-FILING FEES 31167
3 EX-5.1 exhibit51-sx8.htm EX-5.1 13565
4 EX-23.1 exhibit231-sx8.htm EX-23.1 2258
5 EX-23.2 exhibit232-sx8.htm EX-23.2 2531
6 exhibit511aa.jpg GRAPHIC 375723
  Complete submission text file 0001628280-24-024451.txt   645743
Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279572 | Film No.: 24966919
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)